Global Genitourinary Drugs Sales Market Report Forecast 2017 to 2022

September 2017 | 137 pages | ID: GEF9C6D7222EN
S&P Consulting

Abstracts

Delivery of the Report will take 2-3 working days once order is placed.

The report offers a comprehensive evaluation of the market. It does so via in-depth insights, understanding market evolution by tracking historical developments, and analyzing the present scenario and future projections based on optimistic and likely scenarios. Each research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology developments, types, applications, and the competitive landscape.

The study is a source of reliable data on:

• Key market segments and sub-segments
• Evolving market trends and dynamics
• Changing supply and demand scenarios
• Quantifying market opportunities through market sizing and market forecasting
• Tracking current trends/opportunities/challenges
• Competitive insights
• Opportunity mapping in terms of technological breakthroughs

This research report analyzes this market on the basis of its market segments, major geographies, and current market trends. Geographies analyzed under this research report include:
United States
China
Europe
Japan

The Major players reported in the market include:
Astellas
Pfizer
GlaxoSmithKline
Eli Lilly
Bayer AG
Merck
Abbott Laboratories
Bristol-Myers Squibb
Genentech

Product Segment Analysis:
Type 1
Type 2
Type 3

Application Segment Analysis:
Application 1
Application 2
Application 3

Reasons for Buying this Report

• This report provides pin-point analysis for changing competitive dynamics
• It provides a forward looking perspective on different factors driving or restraining market growth
• It provides a six-year forecast assessed on the basis of how the market is predicted to grow
• It helps in understanding the key product segments and their future
• It provides pin point analysis of changing competition dynamics and keeps you ahead of competitors
• It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of market segments

It provides distinctive graphics and exemplified analysis of major market segments

Contents

1 GENITOURINARY DRUGS MARKET OVERVIEW

1.1 Product Overview and Scope of Genitourinary Drugs
1.2 Classification of Genitourinary Drugs
  1.2.1 Type
  1.2.2 Type
  1.2.3 Type
1.3 Application of Genitourinary Drugs
  1.3.2 Application
  1.3.3 Application
  1.3.4 Application
1.4 Genitourinary Drugs Market States Status and Prospect (2012-2022) by Regions
  1.4.1 United States
  1.4.2 China
  1.4.3 Europe
  1.4.4 Japan
1.5 Global Market Size of Genitourinary Drugs (2012-2022)
  1.5.1 Global Genitourinary Drugs Sales and Growth Rate (2012-2022)
  1.5.2 Global Genitourinary Drugs Revenue and Growth Rate (2012-2022)

2 GLOBAL ECONOMIC IMPACT ON GENITOURINARY DRUGS INDUSTRY

2.1 Global Macroeconomic Environment Analysis
  2.1.1 Global Macroeconomic Analysis
  2.1.2 Global Macroeconomic Environment Development Trend
2.2 Global Macroeconomic Environment Analysis by Regions

3 GENITOURINARY DRUGS MANUFACTURING COST ANALYSIS

3.1 Genitourinary Drugs Key Raw Materials Analysis
  3.1.1 Key Raw Materials
  3.1.2 Price Trend of Key Raw Materials
  3.1.3 Key Suppliers of Raw Materials
  3.1.4 Market Concentration Rate of Raw Materials
3.2 Proportion of Manufacturing Cost Structure
  3.2.1 Raw Materials
  3.2.2 Labor Cost
  3.2.3 Manufacturing Process Analysis of Genitourinary Drugs

4 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

4.1 Genitourinary Drugs Industrial Chain Analysis
4.2 Upstream Raw Materials Sourcing
4.3 Raw Materials Sources of Genitourinary Drugs Major Manufacturers in 2016
4.4 Downstream Buyers

5 GLOBAL GENITOURINARY DRUGS COMPETITION BY MANUFACTURERS, TYPE AND APPLICATION

5.1 Global Genitourinary Drugs Market Competition by Manufacturers
  5.1.1 Global Genitourinary Drugs Sales and Market Share of Key Manufacturers (2012-2017)
  5.1.2 Global Genitourinary Drugs Revenue and Share by Manufacturers (2012-2017)
5.2 Global Genitourinary Drugs (Volume and Value) by Type
  5.5.1 Global Genitourinary Drugs Sales and Market Share by Type (2012-2017)
  5.5.2 Global Genitourinary Drugs Revenue and Market Share by Type (2012-2017)
5.3 Global Genitourinary Drugs (Volume and Value) by Regions
  5.3.1 Global Genitourinary Drugs Sales and Market Share by Regions (2012-2017)
  5.3.2 Global Genitourinary Drugs Revenue and Market Share by Regions (2012-2017)
5.4 Global Genitourinary Drugs (Volume) by Application

6 UNITED STATES GENITOURINARY DRUGS (VOLUME, VALUE AND SALES PRICE)

6.1 United States Genitourinary Drugs Sales and Value (2012-2017)
  6.1.1 United States Genitourinary Drugs Sales and Growth Rate (2012-2017)
  6.1.2 United States Genitourinary Drugs Revenue and Growth Rate (2012-2017)
  6.1.3 United States Genitourinary Drugs Sales Price Trend (2012-2017)
6.2 United States Genitourinary Drugs Sales and Market Share by Manufacturers
6.3 United States Genitourinary Drugs Sales and Market Share by Type
6.4 United States Genitourinary Drugs Sales and Market Share by Application

7 CHINA GENITOURINARY DRUGS (VOLUME, VALUE AND SALES PRICE)

7.1 China Genitourinary Drugs Sales and Value (2012-2017)
  7.1.1 China Genitourinary Drugs Sales and Growth Rate (2012-2017)
  7.1.2 China Genitourinary Drugs Revenue and Growth Rate (2012-2017)
  7.1.3 China Genitourinary Drugs Sales Price Trend (2012-2017)
7.2 China Genitourinary Drugs Sales and Market Share by Manufacturers
7.3 China Genitourinary Drugs Sales and Market Share by Type
7.4 China Genitourinary Drugs Sales and Market Share by Application

8 EUROPE GENITOURINARY DRUGS (VOLUME, VALUE AND SALES PRICE)

8.1 Europe Genitourinary Drugs Sales and Value (2012-2017)
  8.1.1 Europe Genitourinary Drugs Sales and Growth Rate (2012-2017)
  8.1.2 Europe Genitourinary Drugs Revenue and Growth Rate (2012-2017)
  8.1.3 Europe Genitourinary Drugs Sales Price Trend (2012-2017)
8.2 Europe Genitourinary Drugs Sales and Market Share by Manufacturers
8.3 Europe Genitourinary Drugs Sales and Market Share by Type
8.4 Europe Genitourinary Drugs Sales and Market Share by Application

9 JAPAN GENITOURINARY DRUGS (VOLUME, VALUE AND SALES PRICE)

9.1 Japan Genitourinary Drugs Sales and Value (2012-2017)
  9.1.1 Japan Genitourinary Drugs Sales and Growth Rate (2012-2017)
  9.1.2 Japan Genitourinary Drugs Revenue and Growth Rate (2012-2017)
  9.1.3 Japan Genitourinary Drugs Sales Price Trend (2012-2017)
9.2 Japan Genitourinary Drugs Sales and Market Share by Manufacturers
9.3 Japan Genitourinary Drugs Sales and Market Share by Type
9.4 Japan Genitourinary Drugs Sales and Market Share by Application

10 GLOBAL GENITOURINARY DRUGS MANUFACTURERS ANALYSIS

10.1 Astellas
  10.1.1 Company Basic Information, Manufacturing Base and Competitors
  10.1.2 Product Type, Application and Specification
  10.1.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  10.1.4 Business Overview
10.2 Pfizer
  10.2.1 Company Basic Information, Manufacturing Base and Competitors
  10.2.2 Product Type, Application and Specification
  10.2.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  10.2.4 Business Overview
10.3 GlaxoSmithKline
  10.3.1 Company Basic Information, Manufacturing Base and Competitors
  10.3.2 Product Type, Application and Specification
  10.3.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  10.3.4 Business Overview
10.4 Eli Lilly
  10.4.1 Company Basic Information, Manufacturing Base and Competitors
  10.4.2 Product Type, Application and Specification
  10.4.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  10.4.4 Business Overview
10.5 Bayer AG
  10.5.1 Company Basic Information, Manufacturing Base and Competitors
  10.5.2 Product Type, Application and Specification
  10.5.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  10.5.4 Business Overview
10.6 Merck
  10.6.1 Company Basic Information, Manufacturing Base and Competitors
  10.6.2 Product Type, Application and Specification
  10.6.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  10.6.4 Business Overview
10.7 Abbott Laboratories
  10.7.1 Company Basic Information, Manufacturing Base and Competitors
  10.7.2 Product Type, Application and Specification
  10.7.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  10.7.4 Business Overview
10.8 Bristol-Myers Squibb
  10.8.1 Company Basic Information, Manufacturing Base and Competitors
  10.8.2 Product Type, Application and Specification
  10.8.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  10.8.4 Business Overview
10.9 Genentech
  10.9.1 Company Basic Information, Manufacturing Base and Competitors
  10.9.2 Product Type, Application and Specification
  10.9.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  10.9.4 Business Overview

11 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

11.1 Marketing Channel
  11.1.1 Direct Marketing
  11.1.2 Indirect Marketing
  11.1.3 Marketing Channel Development Trend
11.2 Market Positioning
  11.2.1 Pricing Strategy
  11.2.2 Brand Strategy
  11.2.3 Target Client
11.3 Distributors/Traders List

12 MARKET EFFECT FACTORS ANALYSIS

12.1 Technology Progress/Risk
  12.1.1 Substitutes Threat
  12.1.2 Technology Progress in Related Industry
12.2 Consumer Needs/Customer Preference Change
12.3 Economic/Political Environmental Change

13 GLOBAL GENITOURINARY DRUGS MARKET FORECAST (2017-2022)

13.1 Global Genitourinary Drugs Sales, Revenue Forecast (2017-2022)
13.2 Global Genitourinary Drugs Sales Forecast by Regions (2017-2022)
13.3 Global Genitourinary Drugs Sales Forecast by Type (2017-2022)
13.4 Global Genitourinary Drugs Sales Forecast by Application (2017-2022)

14 APPENDIX

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Genitourinary Drugs
Table Classification of Genitourinary Drugs
Figure Global Sales Market Share of Genitourinary Drugs by Type in 2016
Table Applications of Genitourinary Drugs
Figure Global Sales Market Share of Genitourinary Drugs by Application in 2016
Figure United States Genitourinary Drugs Revenue and Growth Rate (2012-2022)
Figure China Genitourinary Drugs Revenue and Growth Rate (2012-2022)
Figure Europe Genitourinary Drugs Revenue and Growth Rate (2012-2022)
Figure Japan Genitourinary Drugs Revenue and Growth Rate (2012-2022)
Figure Global Genitourinary Drugs Sales and Growth Rate (2012-2022)
Figure Global Genitourinary Drugs Revenue and Growth Rate (2012-2022)
Table Global Genitourinary Drugs Sales of Key Manufacturers (2012-2017)
Table Global Genitourinary Drugs Sales Share by Manufacturers (2012-2017)
Figure 2015 Genitourinary Drugs Sales Share by Manufacturers
Figure 2016 Genitourinary Drugs Sales Share by Manufacturers
Table Global Genitourinary Drugs Revenue by Manufacturers (2012-2017)
Table Global Genitourinary Drugs Revenue Share by Manufacturers (2012-2017)
Table 2015 Global Genitourinary Drugs Revenue Share by Manufacturers
Table 2016 Global Genitourinary Drugs Revenue Share by Manufacturers
Table Global Genitourinary Drugs Sales and Market Share by Type (2012-2017)
Table Global Genitourinary Drugs Sales Share by Type (2012-2017)
Figure Sales Market Share of Genitourinary Drugs by Type (2012-2017)
Figure Global Genitourinary Drugs Sales Growth Rate by Type (2012-2017)
Table Global Genitourinary Drugs Revenue and Market Share by Type (2012-2017)
Table Global Genitourinary Drugs Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Genitourinary Drugs by Type (2012-2017)
Figure Global Genitourinary Drugs Revenue Growth Rate by Type (2012-2017)
Table Global Genitourinary Drugs Sales and Market Share by Regions (2012-2017)
Table Global Genitourinary Drugs Sales Share by Regions (2012-2017)
Figure Sales Market Share of Genitourinary Drugs by Regions (2012-2017)
Figure Global Genitourinary Drugs Sales Growth Rate by Regions (2012-2017)
Table Global Genitourinary Drugs Revenue and Market Share by Regions (2012-2017)
Table Global Genitourinary Drugs Revenue Share by Regions (2012-2017)
Figure Revenue Market Share of Genitourinary Drugs by Regions (2012-2017)
Figure Global Genitourinary Drugs Revenue Growth Rate by Regions (2012-2017)
Table Global Genitourinary Drugs Sales and Market Share by Application (2012-2017)
Table Global Genitourinary Drugs Sales Share by Application (2012-2017)
Figure Sales Market Share of Genitourinary Drugs by Application (2012-2017)
Figure Global Genitourinary Drugs Sales Growth Rate by Application (2012-2017)
Figure United States Genitourinary Drugs Sales and Growth Rate (2012-2017)
Figure United States Genitourinary Drugs Revenue and Growth Rate (2012-2017)
Figure United States Genitourinary Drugs Sales Price Trend (2012-2017)
Table United States Genitourinary Drugs Sales by Manufacturers (2012-2017)
Table United States Genitourinary Drugs Market Share by Manufacturers (2012-2017)
Table United States Genitourinary Drugs Sales by Type (2012-2017)
Table United States Genitourinary Drugs Market Share by Type (2012-2017)
Table United States Genitourinary Drugs Sales by Application (2012-2017)
Table United States Genitourinary Drugs Market Share by Application (2012-2017)
Figure China Genitourinary Drugs Sales and Growth Rate (2012-2017)
Figure China Genitourinary Drugs Revenue and Growth Rate (2012-2017)
Figure China Genitourinary Drugs Sales Price Trend (2012-2017)
Table China Genitourinary Drugs Sales by Manufacturers (2012-2017)
Table China Genitourinary Drugs Market Share by Manufacturers (2012-2017)
Table China Genitourinary Drugs Sales by Type (2012-2017)
Table China Genitourinary Drugs Market Share by Type (2012-2017)
Table China Genitourinary Drugs Sales by Application (2012-2017)
Table China Genitourinary Drugs Market Share by Application (2012-2017)
Figure Europe Genitourinary Drugs Sales and Growth Rate (2012-2017)
Figure Europe Genitourinary Drugs Revenue and Growth Rate (2012-2017)
Figure Europe Genitourinary Drugs Sales Price Trend (2012-2017)
Table Europe Genitourinary Drugs Sales by Manufacturers (2012-2017)
Table Europe Genitourinary Drugs Market Share by Manufacturers (2012-2017)
Table Europe Genitourinary Drugs Sales by Type (2012-2017)
Table Europe Genitourinary Drugs Market Share by Type (2012-2017)
Table Europe Genitourinary Drugs Sales by Application (2012-2017)
Table Europe Genitourinary Drugs Market Share by Application (2012-2017)
Figure Japan Genitourinary Drugs Sales and Growth Rate (2012-2017)
Figure Japan Genitourinary Drugs Revenue and Growth Rate (2012-2017)
Figure Japan Genitourinary Drugs Sales Price Trend (2012-2017)
Table Japan Genitourinary Drugs Sales by Manufacturers (2012-2017)
Table Japan Genitourinary Drugs Market Share by Manufacturers (2012-2017)
Table Japan Genitourinary Drugs Sales by Type (2012-2017)
Table Japan Genitourinary Drugs Market Share by Type (2012-2017)
Table Japan Genitourinary Drugs Sales by Application (2012-2017)
Table Japan Genitourinary Drugs Market Share by Application (2012-2017)
Table Astellas Basic Information List
Table Astellas Genitourinary Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Astellas Genitourinary Drugs Global Market Share (2012-2017)
Table Pfizer Basic Information List
Table Pfizer Genitourinary Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Pfizer Genitourinary Drugs Global Market Share (2012-2017)
Table GlaxoSmithKline Basic Information List
Table GlaxoSmithKline Genitourinary Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Figure GlaxoSmithKline Genitourinary Drugs Global Market Share (2012-2017)
Table Eli Lilly Basic Information List
Table Eli Lilly Genitourinary Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Eli Lilly Genitourinary Drugs Global Market Share (2012-2017)
Table Bayer AG Basic Information List
Table Bayer AG Genitourinary Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Bayer AG Genitourinary Drugs Global Market Share (2012-2017)
Table Merck Basic Information List
Table Merck Genitourinary Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Merck Genitourinary Drugs Global Market Share (2012-2017)
Table Abbott Laboratories Basic Information List
Table Abbott Laboratories Genitourinary Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Abbott Laboratories Genitourinary Drugs Global Market Share (2012-2017)
Table Bristol-Myers Squibb Basic Information List
Table Bristol-Myers Squibb Genitourinary Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Bristol-Myers Squibb Genitourinary Drugs Global Market Share (2012-2017)
Table Genentech Basic Information List
Table Genentech Genitourinary Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Genentech Genitourinary Drugs Global Market Share (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Genitourinary Drugs
Figure Manufacturing Process Analysis of Genitourinary Drugs
Figure Genitourinary Drugs Industrial Chain Analysis
Table Raw Materials Sources of Genitourinary Drugs Major Manufacturers in 2016
Table Major Buyers of Genitourinary Drugs
Table Distributors/Traders List
Figure Global Genitourinary Drugs Sales and Growth Rate Forecast (2017-2022)
Figure Global Genitourinary Drugs Revenue and Growth Rate Forecast (2017-2022)
Table Global Genitourinary Drugs Sales Forecast by Regions (2017-2022)
Table Global Genitourinary Drugs Sales Forecast by Type (2017-2022)
Table Global Genitourinary Drugs Sales Forecast by Application (2017-2022)

COMPANIES MENTIONED

Astellas
Pfizer
GlaxoSmithKline
Eli Lilly
Bayer AG
Merck
Abbott Laboratories
Bristol-Myers Squibb
Genentech
Roche
Amgen
Botex